Evästeasetukset
Käytämme evästeitä varmistaaksemme, että annamme sinulle parhaan kokemuksen verkkosivustollamme. Lisätietoja on tietosuoja- ja evästekäytännössämme. ...>>>Voit muuttaa asetuksiasi tai peruuttaa suostumuksesi milloin tahansa poistamalla evästeet verkkosivustoltasi tai tietokoneeltasi käytännössä kuvatulla tavalla. Hyväksy se ja valitse mieltymyksesi merkitsemällä vastaavat ruudut alla olevaan "Asetusten hallinta" -osioon. Lue huolellisesti käyttöehdot ennen kuin jatkat minkä tahansa tämän verkkosivuston osan käyttöä. Show vendors
Full Title: Pathophysiological relevance of IRON deficiency and related mitochondrial dysfunction in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF)
Medical condition: Heart failure with preserved ejection fraction
Full Title: An open-label, multi-centre, phase I/IIa study evaluating the safety and clinical activity of neoantigen reactive T cells in patients with metastatic or recurrent melanoma.
Medical condition: Metastatic or recurrent melanoma
Disease:
Version
SOC Term
Classification Code
Term
Level
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10025650
Malignant melanoma
PT
21.1
100000004865
10025651
Malignant melanoma excision
LLT
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10025652
Malignant melanoma in situ
PT
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10025670
Malignant melanoma stage III
PT
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10025671
Malignant melanoma stage IV
PT
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10053571
Melanoma
LLT
20.0
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10027148
Melanoma in situ
LLT
20.0
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10027150
Melanoma malignant
LLT
20.0
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10066600
Melanoma recurrent
PT
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10027480
Metastatic malignant melanoma
PT
20.0
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
10027481
Metastatic melanoma
LLT
21.1
10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Full Title: ICRA (Improve Checkpoint-blockade Response in Advanced urothelial cancer), an adaptive clinical study to determine efficacy of combining weekly paclitaxel with tremelimumab +/- durvalumab (MEDI4736)
Medical condition: Metastatic urothelial carcinoma patients or patients with irresectable disease who were previously treated with chemotherapy - or are cisplatin-ineligible - and have progressed during or after trea...
Sponsor Name: Universitair Medisch Centrum Groningen
Full Title: Short-term safety, efficacy and mode of action of apremilast in mild to moderate cutaneous pemphigoid: a phase IIa open label single arm study.
Full Title: A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the effects of evolocumab added to standard lipid-lowering therapy on fasting and post fat load lipids in pa...
Medical condition: Familial Dysbetalipoproteinemia